Search results
UGA-developed nasal COVID-19 vaccine heading to clinical trials
FOX 5 Atlanta· 3 hours agoUniversity of Georgia researchers have developed a new nasal COVID-19 vaccine, and it's heading for...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 6 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 3 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 12 hours agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Arcturus Therapeutics appoints Moncef Slaoui to board By Investing.com
Investing.com· 2 hours ago(NASDAQ:ARCT), a biotechnology company specializing in mRNA medicines for infectious diseases and...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 23 hours agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 4 days agoModerna recently released results from a phase 3 study for its combo coronavirus/flu vaccine. This...